WR5-31892-47419
3 vaccinations
1 coded response
39 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 222 / VA
- Registered
- 2021-04-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-23
Registered in v-safe
-
2021-04-23
Dose 1 — Moderna
- 2021-04-23
-
2021-04-24
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-25
- 2021-04-26
- 2021-04-27
- 2021-04-28
- 2021-04-29
- 2021-04-30
- 2021-05-07
- 2021-05-14
-
2021-05-28
Dose 2 — Moderna
- 2021-05-28
-
2021-05-29
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-05-30
- 2021-05-31
- 2021-06-01
- 2021-06-02
- 2021-06-04
- 2021-06-11
- 2021-06-18
- 2021-06-25
- 2021-07-02
- 2021-07-09
- 2021-08-27
- 2021-11-28
-
2021-12-14
Dose 3 — ModernaCo-administered: Flu
-
2021-12-15
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Headache, NauseaAdult check-in
- 2021-12-16
- 2021-12-17
- 2021-12-18
- 2021-12-19
- 2021-12-20
- 2021-12-21
- 2021-12-28
- 2022-01-04
- 2022-01-11
- 2022-01-18
- 2022-01-25
- 2022-03-15
- 2022-06-14
-
2022-12-14
Survey response — 12 months, dose 3MedDRA: Hyperthyroidism — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: HyperthyroidismMedDRA releases: 2024-11 · check-in free text available
-
2022-12-14
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-12-15
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-23 | Moderna | |
| 2 | 2021-05-28 | Moderna | |
| 3 | 2021-12-14 | Moderna | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-12-14 | Unsuccessful |
Free text
Release 12 — 12 months, dose 3
Symptoms: Hyperthyroidism
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Hyperthyroidism | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release